A Study for the PanCystPro Assay in the Management of Pancreatic Cystic Lesions
Launched by AMPLIFIED SCIENCES INC · Mar 24, 2025
Trial Information
Current as of April 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a test called the PanCystPro assay, which helps doctors decide how to treat and monitor pancreatic cysts. The test looks at certain markers in the fluid taken from the cyst to determine if it is "Non-mucinous" or "Mucinous." Mucinous cysts have a higher chance of turning into cancer, while non-mucinous cysts are less likely to do so. By understanding the type of cyst, doctors can make better treatment decisions for patients.
To participate in this trial, you need to be at least 18 years old and have a pancreatic cyst that is at least 12 mm in size, as seen on imaging tests. You'll also need to provide written consent and be scheduled for an endoscopic ultrasound (EUS) where fluid will be taken from the cyst. However, if you have pancreatic cancer, are pregnant or breastfeeding, or have certain health issues that make sedation risky, you won't be eligible. This trial is not yet recruiting participants, but it aims to improve how doctors manage pancreatic cysts and potentially catch problems earlier.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients 18 years of age or older
- • Cross sectional imaging studies demonstrating a pancreatic cyst at least 12 mm in size where fluid sampling can aid in patient's management
- • Written informed consent.
- • The patient will be undergoing EUS with anticipated FNA extraction as part of standard patient care.
- Exclusion Criteria:
- • Patients diagnosed with pancreatic cancer.
- • Pregnant or lactating females.
- • Patients with contraindications to moderate or deep procedural sedation (necessary for the conduct of the endoscopic ultrasound) like major cardiorespiratory illness.
- • Patients with contraindications to FNA of a pancreatic cyst like being on blood thinners.
About Amplified Sciences Inc
Amplified Sciences Inc. is a pioneering clinical trial sponsor dedicated to advancing healthcare through innovative research and development. With a focus on leveraging cutting-edge technologies and methodologies, the company conducts rigorous clinical trials aimed at evaluating the safety and efficacy of novel therapeutics and medical devices. Amplified Sciences is committed to enhancing patient outcomes and accelerating the path to market for breakthrough treatments, all while adhering to the highest standards of regulatory compliance and ethical practices. Through strategic partnerships and a collaborative approach, the organization strives to make a significant impact in the medical community and improve the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported